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Background: Depression before and during pregnancy is associated with adverse birth outcomes including low
birth weight and preterm birth. Abnormal maternal cortisol has been hypothesized as one mediator between
depression and adverse birth outcomes. The relationship between cortisol and depression in pregnancy is exhibited
most strongly in the African American population, and most studies have focused either on circulating or placental
levels of cortisol. The utility of urinary cortisol in early pregnancy related to depression and adiposity has not been
investigated.
Methods: Twenty-five pregnant African American women identified by the Edinburgh Depression Scale as having
depression were investigated and matched by body mass index (BMI), age, race, and infant birth weight centile to
non-depressed subjects. Maternal urine and plasma cortisol in early pregnancy were quantified and investigated in
relation to depression and adiposity.
Results: Morning urine cortisol levels tracked positively with plasma cortisol (r2 = 0.25, p < 0.001). However, no
differences were observed in either urinary or plasma cortisol between depressed and non-depressed pregnant
women. Plasma cortisol was significantly negatively associated with several measures of maternal adiposity including
percent body fat (r2 = −0.10, p < 0.05), however this relationship was present only in the non-depressed women. In a
post-hoc analysis, non-depressed non-obese women were found to have significantly higher cortisol levels compared
to women with depression, obesity or both (p < 0.05).
Conclusions: Depressed pregnant women and non-depressed obese pregnant women evidence atypical cortisol
levels compared to non-depressed non-obese pregnant women. Plasma cortisol in early pregnancy is negatively
associated with measures of maternal adiposity. Atypical low circulating maternal cortisol among depressed (lean and
obese) and non-depressed obese pregnant African American women may indicate hypothalamic-pituitary axis
dysfunction in early pregnancy.
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Postnatal depression is an important focus of appropriate
clinical care for expectant mothers; however, antenatal de-
pression is also of clinical concern [1]. Depression during
pregnancy has been linked to pregnancy complications
including preeclampsia, and adverse birth outcomes such
as preterm birth and low birth weight which are leading
causes of pregnancy related morbidity and mortality [2].
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unless otherwise stated.outcomes is unclear, and several factors have been ex-
amined including inflammation and dysregulation of
the hypothalamic-pituitary axis (HPA) [3,4]. Depression
and anxiety during pregnancy have been associated with
elevated maternal cortisol levels and a negative evaluation
of pregnancy [5].
The steroid hormone cortisol is produced by the ad-
renal cortex in response to stress. Cortisol’s primary
functions involve affecting metabolism and the immune
system, and it is involved as negative feedback in the in-
flammatory process [6]. Cortisol is also an important
factor during pregnancy with increased levels driven by
placental production of cortisol releasing factor (CRF)his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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drives HPA output, increased placental 11 beta hydroxy-
steroid dehydrogenase 2 (11β-HSD2) activity protects
the fetus from adverse effects of elevated systemic ma-
ternal cortisol levels [8]. Elevated maternal cortisol in
early pregnancy is implicated in preterm birth as a result
of an earlier than expected spike in placental CRF com-
pared to full-term pregnancies [9]. Elevations in placen-
tal cortisol are also found in preterm birth and low birth
weight pregnancies associated with preeclampsia, and
suggest that cortisol may play a role in the physiological
mechanism linking depression and adverse birth out-
come [10].
Several factors influence the relationship between de-
pression and birth outcome. In the US and other countries,
women of low socioeconomic status (SES) have a higher
rate of depression [11]. Black women have a disproportion-
ate burden of socioeconomic stresses and poor birth out-
comes [12]. It has also been shown that black women,
independent of SES, report more depressive symptoms
during pregnancy than white women, and are also more
likely to have adverse birth outcomes [2,13]. Greater
elevations in inflammatory markers and stress markers
associated with depression are also more evident in
black women [13]. In a longitudinal study of 2544 sub-
jects, the inflammatory marker c-reactive protein was
more closely related to depression in black compared to
white subjects [13]. Obesity was also found to mediate
physiologic responses to stress and that depressive
symptoms are associated with increased inflammation
among pregnant black women, suggesting an imbalance
of pro- and anti-inflammatory factors [3]. Therefore,
understanding the physiologic underpinnings linking
depression, adiposity and adverse birth outcomes among
black women is important in determining appropriate
clinical approaches to at-risk patients during pregnancy.
The focus of this study was to investigate if maternal urine
cortisol in early pregnancy was significantly elevated in
black women with depression compared to women with-
out depression. In addition, we sought to compare urine
cortisol values to circulating plasma values in early preg-
nancy, and to investigate the relationship of maternal
urine and plasma cortisol values to depression and adi-
posity among a cohort of black women recruited in early
pregnancy.
Methods
Subjects
The study was conducted between April 2009 and
February 2013 in a sample of 50 healthy nulliparous
women with a singleton pregnancy without known medical
complications recruited early in the first trimester (11.2 ±
3.1 weeks gestation, average ± SD). This was a case–control
study from an ongoing longitudinal investigation ofpregnancy (Prenatal Exposures and Preeclampsia Preven-
tion (PEPP)) at the University of Pittsburgh, Magee-
Womens Hospital and Magee-Womens Research Institute.
Subjects were recruited from the western Pennsylvania re-
gion and were all seeking prenatal care at Magee-Womens
Hospital of UPMC. The ethnicity of the five county area of
western Pennsylvania is primarily Caucasian (~70%) and
African American (~20%). Race was self-assigned as black
or African American for all subjects in this study [14,15].
Exclusion criteria included chronic hypertension, pre-
gestational diabetes on medication (insulin, glyburide),
major fetal anomaly or demise, planned termination
of the pregnancy, collagen vascular disease (autoimmune
disease) on medication, renal disease, epilepsy or other
seizure disorder, active or chronic liver disease, heart dis-
ease, known illicit drug or alcohol abuse during current
pregnancy. Obesity was defined as pre-pregnancy body
mass index (BMI) of ≥ 30 kg/m2. The study was approved
by the University of Pittsburgh institutional review board.
Subjects were recruited at the time of presentation to
Magee-Womens Hospital for prenatal care. All pregnant
women were informed about the study and gave written
informed consent at study enrollment.
Assessments
All subjects were enrolled early in the first trimester, 11.3 ±
3.2 weeks gestation for the non-depressed controls and
11.1 ± 3.1 weeks gestation for depression cases. Depressive
symptoms were assessed using the Edinburgh Depression
Scale (EDS), a previously validated scale for detection of
depression during pregnancy [16], a 10-item screening tool
providing an indication of the severity of symptoms. The
PEPP study was designed such that the EDS was adminis-
tered to all subjects only at study enrollment. Women with
EDS scores greater than or equal to 11 at the time of study
enrollment were identified as depression cases (n = 25,
average EDS score 14.1 ± 2.3); and this corresponded to the
upper 5% of depression scores in this study population.
Eight (8) of the 25 women with an EDS score of 11 or
greater had a history of depression, and 1 non-depressed
woman had a past history of depression treated without
medication. Overall the women in this study were healthy,
and none were being treated with anti-depressant medica-
tion at the time of this study. None of the women in this
study were currently being treated with antidepressant
medication. Subjects with depression were matched 1-to-1
by maternal age, race, pre-pregnancy body mass index
(BMI), gestational age at delivery, and infant birth weight
centile to non-depressed uncomplicated control pregnant
women (n = 25, average EDS score 3.0 ± 2.3).
Blood and urine samples
Maternal venous EDTA plasma samples were collected
at study enrollment between 6–16 weeks gestation. In
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the same time as maternal EDTA plasma. Midstream
clean catch urine specimens were collected first thing in
the morning in the hospital clinic and processed within
an hour. Samples were collected between April 2009 and
February 2013 and stored at −70°C for later analysis.
With the sample size of 50 women, a medium effect size
of 0.30 can be detected between depressed and non-
depressed women with 0.80 power at a two-tailed signifi-
cance level of 0.05.
Cortisol quantitation
Maternal plasma and urine cortisol concentrations were
determined using a competitive ELISA kit from R&D
Systems (KGE008, Minneapolis, MN) according to the
manufacturer’s instructions. This assay has been validated.
The intra- and inter-assay coefficient of variation of the
assay is between 5 to 9%. The ELISA is sensitive with a
reported sensitivity of 150 pg/ml compared to measured
concentrations of cortisol between 14 to 100 ng/ml in
plasma from pregnant women. Specificity and no cross
reactivity were observed in the assay for other hormones
including: prednisolone, Reichstein’s substance S, proges-
terone, cortisone, 4-androstene-3,17 dione, corticosterone,
deoxycorticosterone, estradiol, and prednisone.
All maternal samples were analyzed in duplicate, and
laboratory personnel were unaware of the case–control
status of the study subjects at the time of analysis. In
general, samples were diluted 1 to 20 or 1 to 40 in order
for samples to fall within the linear and measurable
range of the assay’s standard curve.
Creatinine quantitation
Urine creatinine concentrations were determined using
colorimetric reaction (Pointe Scientific, Canton, MI). All
samples were assayed in duplicate. The average within-
assay coefficient of variation for creatinine was 3.9%, and
the inter-assay variability was 7.9%.
Adiposity measures
Bioelectrical impedance analysis (BIA) was measured to
determine maternal body composition and adiposity
using the RJL Systems BIA Quantum IV (RJL System,
Clinton Twp, MI, USA). Each participant was instructed
to remove her right shoe and sock, and then lie supine
with her arms away from her body. Two electrodes were
placed on the right hand, one on the wrist and one on
the first joint of the middle finger. Two electrodes were
placed on the right foot, one on the ankle and the other
on the base of the second toe. Direct measures of resist-
ance (R), reactance (Xc), and impedance (I) were recorded.
Hematocrit was measured by centrifugation of whole
blood in glass capillary tubes and measured red cell vol-
ume. Fat mass and percent body fat were calculated usingpublished formulas specific for pregnancy [17,18]. Mater-
nal height, weight, hip circumference, and waist circum-
ference were determined by standard clinical measures.
Waist to hip ratio (WHR) was calculated using measure-
ments conducted at study enrollment in the first trimester
before the gravid uterus had begun to change the contour
of the participant’s mid abdomen [19].
Statistical analysis
Continuous data are presented as means and standard
deviations (SD), and categorical data are expressed as
numbers and percentages. Pregnant women with depres-
sion and non-depressed control women were matched
1-to-1 by maternal age, race, pre-pregnancy body mass
index (BMI), gestational age at delivery, and infant birth
weight centile and unpaired analyses were used to com-
pare characteristics between groups (chi-square or t-test).
Differences in maternal plasma and urine cortisol
concentrations between women with depression and
non-depressed control women were assessed using Stu-
dent’s t-test or ANOVA. Correlations were by standard
regression analysis with the square of the Pearson’s prod-
uct moment reported (r2). Tests were 2-sided and statis-
tical significance was accepted at p < 0.05.
Results
The maternal and newborn characteristics of the study
subjects are shown in Table 1. By design, depressed
pregnant black women were matched to non-depressed
pregnant black women by maternal age, weight, and
body mass index (BMI). In addition there was no differ-
ence in maternal fat mass, percent body fat, waist/ hip
ratio, blood pressure at enrollment, gestational age at
delivery, infant birth weight and birth weight centile
(Table 1). There was no difference in smoking status
between depressed and non-depressed women. Both
groups were primarily of low income, and most only
had a high school education or less (Table 1). All pregnant
black women in this study had uncomplicated pregnan-
cies. Lastly, by design, the Edinburgh depression score
at study enrollment was significantly elevated in the
depressed pregnant black women (14.1 ± 2.3) compared
to the non-depressed pregnant black women (3.0 ±
2.3, p < 0.0001).
Comparison of maternal plasma and urine cortisol
There was no correlation between maternal plasma or
urine cortisol values and gestational age at collection;
plasma r2 = 0.03, p = 0.25 and urine r2 = 0.02, p = 0.29.
We first set out to investigate and compare maternal
urine cortisol values compared to maternal plasma sam-
ples collected at the same time. As shown in Figure 1,
the maternal urine cortisol/ creatinine ratio was signifi-
cantly and positively correlated to maternal plasma cortisol
Table 1 Maternal and newborn characteristics of study
subjects
Non-depressed
control subjects
(n = 25)
Depressed
subjects
(n = 25)
Maternal age (years) 22.2 ± 3.0 22.3 ± 3.1
Maternal weight (lbs) 179.8 ± 43.1 181.7 ± 45.4
Pre-pregnancy body
mass index (BMI) (kg/m2)
30.3 ± 7.4 31.5 ± 7.7
Fat mass (lbs) 73.1 ± 33.3 71.4 ± 32.9
Percent body fat (%) 38.8 ± 8.1 37.4 ± 8.2
Waist/ hip ratio 0.857 ± 0.057 0.858 ± 0.080
Race (Black) n (%) 25 (100%) 25 (100%)
Average blood pressure
at enrollment (mmHg)
113 ± 9/67 ± 7 110 ± 9/66 ± 7
Gestational age at
delivery (weeks)
38.9 ± 1.6 39.5 ± 1.3
Infant birth weight (grams) 3254 ± 523 3274 ± 432
Infant birth weight centile (%) 58.9 ± 28.8 56.5 ± 24.4
Cigarette Smoker, n (%) 7/25 (28%) 13/25 (52%)
Household income
<$10,000 20/25 (80%) 18/25 (72%)
$10-34,999 4/25 (16%) 5/25 (20%)
$35,000+ 1/25 (4%) 2/25 (8%)
Education level
Some high school or GED 17/25 (68%) 21/25 (84%)
Some college or associate
degree
8/25 (32%) 4/25 (16%)
Edinburgh Depression Scale
(EDS) score at study enrollment
3.0 ± 2.3 14.1 ± 2.3 *
Data are mean ± SD. *: p < 0.0001 compared to non-depressed control subjects.
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ternal plasma and the urine cortisol/ creatinine ratio was
maintained in both the depressed pregnant women alone
(r2 = 0.22, p < 0.02) and the non-depressed pregnant women
alone (r2 = 0.28, p < 0.01).
Maternal cortisol and depression
We next investigated differences in cortisol levels in
early pregnancy between depressed and non-depressed
pregnant black women. As shown in Table 2 neither
plasma cortisol nor the urine cortisol/creatinine ratio
was significantly different between depressed and non-
depressed pregnant black women.
Maternal cortisol and adiposity
Several measures of adiposity were evaluated in the
pregnant women in this study including BMI, waist-hip
ratio (WHR), fat mass, and percent body fat. Surprisingly,
despite measurements occurring in early pregnancy, there
was a significant positive relationship between maternalWHR and gestational age (r2 = 0.11, p < 0.05), but no rela-
tionship between other measures of maternal adiposity
and gestational age. There was no significant relationship
between the urine cortisol/creatinine ratio and maternal
measures of adiposity. In contrast to urine cortisol, ma-
ternal plasma cortisol was significantly and negatively
associated with maternal weight (r2 = −0.10, p < 0.05),
fat mass (r2 = −0.10, p < 0.05), percent fat mass (r2 = −0.10,
p < 0.05), and was close to statistical significance for ma-
ternal BMI (r2 = −0.07, p = 0.06). Plasma cortisol was not
associated with WHR (p = 0.98). Upon subgroup analysis,
the relationship between plasma cortisol and maternal
adiposity was only present in the non-depressed pregnant
black women (weight r2 = −0.31, p < 0.005; BMI r2 = −0.29,
p < 0.01, fat mass r2 = −0.29, p < 0.01, and percent body fat
r2 = −0.26, p < 0.01), but not present in the depressed
pregnant black women. Figure 2 illustrates the relation-
ship between plasma cortisol and maternal percent body
fat for both the depressed (p = 0.78) and non-depressed
(p < 0.01) pregnant women.
Interaction between cortisol, adiposity and depression
We further investigated the relationship and interaction
of maternal adiposity to plasma cortisol and depression.
As shown in Figure 3, maternal plasma cortisol levels
were significantly elevated among the non-depressed
non-obese pregnant black women (n = 13) compared to
pregnant non-depressed obese women (n = 12). In con-
trast, there was no difference in plasma cortisol between
depressed non-obese and obese pregnant black women.
In addition, in a subgroup analysis, plasma cortisol was
significantly elevated in the non-depressed non-obese
pregnant black women compared to the other three sub-
groups (p < 0.05).
Discussion
In this study we found no difference in plasma or urin-
ary cortisol levels between depressed and non-depressed
pregnant black women in early pregnancy. In contrast,
plasma cortisol levels were negatively associated with
several measures of maternal adiposity, and additional
analysis revealed this relationship to be present only in
the non-depressed pregnant black women. The HPA axis
through the action of cortisol may be a mechanism by
which stressors, including depression, adversely affect
pregnancy and birth outcomes (e.g., preterm birth and
low birth weight) [1,2,4]. This study examined the rela-
tionship and interaction between depression and mater-
nal cortisol levels in black women in early pregnancy,
including comparing early morning plasma and urine
cortisol levels. These data suggest maternal cortisol
values may be negatively affected by adiposity and stressors
such as depression may contribute to atypical low cortisol
levels.
Figure 1 Correlation of maternal plasma cortisol and urine cortisol between depressed and non-depressed pregnant women. Trend line
for all study subjects is the solid black line (r2 = 0.25, p < 0.001). Trend line for the depressed subjects only (closed symbols) is the fine dashed line
(r2 = 0.22, p < 0.02), and the trend line for the non-depressed subjects only (open symbols) is the heavy dashed line (r2 = 0.28, p < 0.01).
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elevations beginning early in pregnancy, and cortisol
playing a role in parturition [7]. Physiologic responses to
stressors typically involve elevations in HPA axis activity
and elevated cortisol. In pregnancy, placental CRF par-
ticipates in a feed forward loop, and the maternal nega-
tive feedback mechanisms are down regulated leading to
elevated cortisol levels [8]. Previous studies have impli-
cated both depression and cortisol in pregnancy complica-
tions such as preeclampsia and adverse birth outcomes
such as preterm birth and low birth weight [2]. Further-
more, studies have observed differences in biomarkers
related to stress between depressive symptoms depending
upon the study subject’s race [13]. In our study, stressors
including depression and increased adiposity may blunt
the physiologic HPA response in normal pregnancy and
result in low morning cortisol levels.
One focus of this study was to compare maternal
plasma and urine cortisol levels in order to investigate ifTable 2 Differences in maternal plasma and urine cortisol me
Non-depre
Gestational age at sample collection (weeks gestation) 11.3 ± 3.2
Maternal plasma cortisol (ng/ml) 31.5 (20.1,
Maternal urine cortisol/ creatinine ratio 0.99 (0.66,
Data are mean ± SD or median (interquartile range).urine cortisol measures might be an easily accessible
biological material to assess maternal cortisol levels.
While other studies have investigated salivary cortisol,
we hypothesized maternal urine may serve as a useful
depot for assessing cortisol levels. We did observe a
significant positive, although modest, relationship be-
tween maternal plasma and urine cortisol levels. How-
ever, additional analyses did not provide any useful
relationships between maternal urine cortisol levels and
depression or adiposity among the pregnant women in
this study.
The link between depression and poor birth outcomes
is thought to be mediated through physiologic changes
secondary to depression including elevated cortisol and
pro-inflammatory factors [3]. In our study there was no
significant difference in maternal cortisol levels between
depressed and non-depressed pregnant black women.
Previous research suggests that subtypes of depression
may alter HPA axis functioning with either hyperactivityasures
ssed control subjects (n = 25) Depressed subjects (n = 25)
11.1 ± 3.1
44.7) 30.6 (21.2, 41.2)
1.60) 0.71 (0.55, 1.18)
Figure 2 Correlation of maternal plasma cortisol and maternal
percent body fat (%) for depressed (closed symbols) and
non-depressed (open symbols) pregnant women. Trend line for
the depressed subjects is the solid black line (r2 = 0.003, p = 0.78), and
the trend line for the non-depressed subjects is the heavy dashed line
(r2 = −0.26, p < 0.01). The correlation between plasma cortisol and
percent body fat among the non-depressed women persisted after
exclusion of the highest cortisol value, (r2 = −0.32, p < 0.01).
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pression) [20]. The depressed pregnant women in this
study were assessed by the EDS, however it is possible
these women may comprise a heterogenous group of de-
pressed women including both melancholic and atypical
depressive subtypes, perhaps obfuscating relationships
between depression and cortisol.Figure 3 Box and whisker plots of maternal plasma cortisol (ng/ml) b
the open circles are the 90th and 10th percentiles, and the top and bottom
each group. Statistical significance is indicated by p values.While elevated cortisol is related to central adiposity
in non-pregnant women [21], measures of adiposity were
negatively correlated with plasma cortisol in our sample.
This result may be related to the flattening of the diurnal
cortisol curve observed in obese patients [22]. Typically,
HPA axis dysfunction is seen in adiposity involving
greater activation due to stress stimulation. In contrast,
it has been found that while cortisol is positively corre-
lated with central adiposity, the waking cortisol response
can be blunted in obese subjects [22]. Our data showing
a negative correlation between adiposity and morning
plasma cortisol are consistent with this previous finding.
Elevated cortisol leads to central adiposity, and is
associated with a flattened diurnal curve of cortisol [22].
Therefore, maternal adiposity is an expected factor con-
tributing to atypical low morning cortisol. In addition,
post-hoc analysis identified non-depressed non-obese
women as having significantly elevated cortisol levels
compared to depressed obese and non-obese women,
and non-depressed obese pregnant black women. Depres-
sion is thought to be the result of both hyper- and hypo-
responsiveness of the HPA axis [20,23]. Interestingly,
while depressive subtype (atypical vs. melancholic) could
be correlated with elevated or depressed HPA axis activity,
depressed obese and non-obese pregnant black women in
this study had lower cortisol levels when compared to
non-depressed non-obese women. Atypical low morning
cortisol in early pregnancy may be an indicator of HPA
dysfunction, however, additional research that includes
adverse pregnancy outcomes is needed to determine if
these atypical cortisol levels may constitute a marker for
risk later in pregnancy.
The observation of atypical morning maternal cortisol
levels among pregnant depressed obese black women isy depression and adiposity. The filled black circles are the median,
lines of the box are the 75th and 25th percentiles of the data for
Luiza et al. BMC Pregnancy and Childbirth  (2015) 15:30 Page 7 of 8unique. However, there are several limitations inherent
to the current study as a result of design. A major
limitation of this study is the classification of depres-
sion using the Edinburgh Depression Rating Scale. The
Edinburgh scale is a screening tool for depression vali-
dated for use during pregnancy [16], but it does not
replace more formal structured psychiatric assessments
for depression. Of note, many of the depressed subjects in
this study were noted to have a history of depression and
anxiety, but this information was not complete for all sub-
jects. An additional significant limitation of this study is the
single morning urine sample which prevented us from ac-
curately determining the diurnal variation in cortisol. In
addition, the relatively small sample size of the current
study is a limitation, however this study was focused solely
on investigating depressed and non-depressed black women
in early pregnancy which inherently limited the potential
pool of subjects eligible for investigation. In addition, the
current study only investigated maternal cortisol levels in
uncomplicated pregnant women. However, this limitation
was by design since we wished to eliminate adverse preg-
nancy outcomes as a potential confounder of dysregulated
cortisol levels in pregnancy. Similarly, this study only inves-
tigated pregnant black women; however again this limita-
tion was by design since we were specifically interested in
and hypothesized that atypical and dysregulated maternal
cortisol levels would be evident among pregnant black
women. Lastly, while all urine samples in this study were
early morning collections, we were unable to obtain sam-
ples collected by standardized methods. Despite this limita-
tion we did observe a significant and positive correlation
between urine and circulating plasma cortisol levels.
Conclusions
In this case–control study we investigated cortisol levels
in pregnant women with uncomplicated pregnancies to
examine the relationship between adiposity, depression
and cortisol. We observed elevated circulating maternal
cortisol levels in non-depressed non-obese pregnant
black women compared to depressed obese pregnant
black women, consistent with elevated cortisol noted in
pregnancy. In addition, we observed an atypical blunting
of maternal cortisol levels among obese depressed and
non-depressed pregnant black women and non-obese
depressed pregnant black women. We hypothesize these
data indicate HPA axis dysfunction in early pregnancy.
Both depression and adiposity may influence this rela-
tionship. Future studies should further investigate this
relationship and should include women with adverse
pregnancy outcomes including preterm birth and fetal
growth restriction.
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